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Background: In Plasmodium falciparum infection, peripheral parasite counts do not always correlate well with the
sequestered parasite burden. As erythrocytes parasitized with mature trophozoites and schizonts have a high
tendency to adhere to the microvascular endothelium, they are often absent in peripheral blood samples. The
appearance of schizonts in peripheral blood smears is thought to be a marker of high sequestered parasite burden
and severe disease. In the present study, the value of schizontaemia as an early marker for severe disease in
non-immune individuals with imported malaria was evaluated.
Methods: All patients in the Rotterdam Malaria Cohort diagnosed with P. falciparum malaria between 1 January
1999 and 1 January 2012 were included. Thick and thin blood films were examined for the presence of
schizontaemia. The occurrence of WHO defined severe malaria was the primary endpoint. The diagnostic
performance of schizontaemia was compared with previously evaluated biomarkers C-reactive protein and lactate.
Results: Schizonts were present on admission in 49 of 401 (12.2%) patients. Patients with schizontaemia were more
likely to present with severe malaria, a more complicated course and had longer duration of admission in hospital.
Schizontaemia had a specificity of 0.95, a sensitivity of 0.53, a negative predictive value of 0.92 and a positive
predictive value of 0.67 for severe malaria. The presence of schizonts was an independent predictor for severe
malaria.
Conclusion: Absence of schizonts was found to be a specific marker for exclusion of severe malaria. Presence of
schizonts on admission was associated with a high positive predictive value for severe malaria. This may be of help
to identify patients who are at risk of a more severe course than would be expected when considering peripheral
parasitaemia alone.
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Sequestration of infected erythrocytes in the microvascu-
lature is one of the main pathological features of severe
Plasmodium falciparum infection [1-4]. Particularly,
erythrocytes parasitized with mature trophozoites and
schizonts have a high tendency to adhere to the
microvascular endothelium and are therefore often ab-
sent in collected peripheral blood samples. However, the
appearance of schizonts in peripheral blood smears is* Correspondence: p.van.genderen@havenziekenhuis.nl
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distribution, and reproduction in any mediumthought to reflect a high sequestered parasite burden and
was recognized as a sign of severe disease already in early
field studies on malaria [5]. The predominance of mature
parasites on peripheral smears was found to reflect more
severe disease by Silamut and White [6], but only a few
other studies on the performance of schizontaemia as a
predictor for severe disease have been done [7-9]. In
addition, data is only available from studies in areas with
malaria endemicity where many inhabitants are believed
to have some degree of immunity toward malaria (so-
called semi-immunity). Data in non-immune individuals
are lacking.
Although it is stated in the current WHO malaria
guidelines that the presence of schizontaemia may bed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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aria, presence of schizonts is currently not a well-
established WHO criterion for severe disease [9,10]. To
further explore the value of schizontaemia as an early
marker for severe disease in non-immune individuals
with imported malaria, the prognostic value of schizon-
taemia was assessed in a large cohort of travellers with
P. falciparum malaria.
Methods
Patients
The Harbour Hospital is a 161-bed general hospital
located in Rotterdam, The Netherlands. It comprises the
Institute for Tropical Diseases, which serves as a national
referral centre. All patients in the Rotterdam Malaria Co-
hort diagnosed with P. falciparum malaria between 1
January 1999 and 1 January 2012 were included in this ob-
servational study. Of all patients identified, demographic,
clinical and laboratory data were collected using a standar-
dized form and stored in an electronic database. Patients
with a mixed infection of P. falciparum with another Plas-
modium species were included in this study, but pure
non-falciparum Plasmodium infections were excluded.
Multiple malaria episodes in a single patient were only
regarded as separate cases if caused by true re-infection;
recrudescent infections of P. falciparum were excluded.
Laboratory investigations
Available laboratory examinations included red and white
blood cell counts, haematocrit, platelet counts, C-reactive
protein, serum electrolytes, total bilirubin, serum creatinine
and urea, sodium, potassium, liver enzymes, blood glucose
and venous plasma lactate.
Detection of Plasmodium parasites
The standard procedure to diagnose malaria comprised
a quantitative buffy coat (QBC) analysis, a rapid diagnos-
tic test (RDT) for malaria antigens Binax NOWW Mal-
aria Test (Binax, Inc, Maine, USA), and thick and thin
blood smears using freshly collected blood specimens
from finger pricks. The malaria rapid test and the QBC
analysis were performed according to the manufacturer’s
instructions. QBC capillaries were examined independ-
ently by two technicians by microscopic analysis of two
complete rows of the region between the bottom of the
capillary and the polynuclear leukocyte layer using an
Olympus BX-60 fluorescence microscope equipped UV-
filter and 50x objective and 12.5x oculars (total magnifi-
cation 625x). These two lanes represented about 100
microscopic fields (at 625x magnification) and took an
average examination time of 5 min. Subsequently, the
polynuclear and mononuclear cell layer was screened for
schizonts, gametocytes, malaria pigment and elderly tro-
phozoites of Plasmodium vivax and Plasmodium ovale.Thick blood smears were stained with Field’s stain
(Brunschwig Chemie, Amsterdam, The Netherlands) and
thin smears with Diff Quick stain (Medion Diagnostics,
Düdingen, Switzerland). Both staining procedures had
been optimized for optimal staining of Plasmodium
parasites as well as Schüffner’s dots and Maurer’s clefts
in infected erythrocytes. Thick and thin smears were
examined with regular light microscopes at a total mag-
nification of 1,250x. The Plasmodium species was identi-
fied on morphological characteristics in the thin and
thick blood smears. Since a real-time quantitative PCR
became available several years ago, a substantial propor-
tion of the samples were additionally confirmed by PCR
(without discrepant findings compared to classic light
microscopy).
Parasite counting and identification of Plasmodium
falciparum schizonts
Parasitaemia was determined by parasite counting as
described before [11]. Plasmodium falciparum schizonts
were defined as clustered malaria pigment adjacent to two
or more nuclei of P. falciparum in thick blood smears or
QBC capillaries. Compared to thin and thick blood smears
QBC analysis is the most sensitive test to detect Plasmo-
dium parasites. Plasmodium falciparum schizonts can be
identified in the erythrocyte layer in the QBC capillary,
but identification within the leukocyte layer is difficult due
to the intense fluorescent signal of the leukocyte nuclei.
For this reason, this layer is also screened for quenched
fluorescence by malaria pigment. If malaria pigment was
detected in the leukocyte layer of the QBC capillary, the
thick and thin blood smears were thoroughly examined
for the presence of schizonts by analysis of at least 200
microscopic fields at 625x magnification.
Definitions
Severe malaria
Patients were classified as having severe malaria if they
met one or more of the WHO criteria for severe malaria,
as published [9], either on presentation or later during
hospital admission.
Schizontaemia
Schizontaemia was defined as presence of one or more
P. falciparum schizonts identified in QBC and/or blood
smear examinations from a blood sample taken on
admission.
Immunity to malaria
The degree of immunity to malaria was estimated as
previously described [12]. In brief, adult immigrants
from a malaria-endemic country living in The Nether-
lands were considered partially immune. Immigrant
patients who had been living in a malaria-endemic area
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sumed semi-immune. Tourists from non-endemic coun-
tries who travelled to malaria-endemic regions were
considered non-immune.Table 1 General characteristics of patients with imported Plas
absence of schizontaemia on admission
All patients
n= 401
Demographic s
Age, years 39 (4–78)
Male, female, n (%) 292 (72.8), 109 (27.2)
Continent of acquisition
Africa, n (%) 360 (89.8)
Asia, n (%) 16 (4.0)
South and Central America, n (%) 10 (2.5)
Unknown, n (%) 15 (3.7)
Duration of signs/symptoms
<8 days, n (%) 259 (64.6)
8-14 days, n (%) 74 (18.5)
15-28 days, n (%) 27 (6.7)
>28 days, n (%) 8 (2.0)
Unknown, n (%) 33 (8.2)
Use of malaria chemoprophylaxis
No chemoprophylaxis, n (%) 272 (67.8)
Inadequate use, n (%) 72 (18.0)
Adequate use, n (%) 39 (9.7)
Unknown, n (%) 18 (4.5)
Vital signs on admission
Body temperature, °C 38.5 (35.5-41.2)
Pulse rate, beats per minute 95 (45–150)
Systolic blood pressure, mm Hg 120 (64–190)
Impaired consciousness (GCS< 15), n (%) 9 (2.2)
Cerebral malaria (GCS≤ 11), n (%) 5 (1.2)
Laboratory data on admission
Haemoglobin, mmol/L 8.3 (2.5-11.1)
Leucocyte count, x 109/L 5.1 (1.3-18.5)
Thrombocytes, x 109/L 86 (2–385)
C-reactive protein, mg/L 98 (5–476)
Serum creatinine, μmol/L 95 (39–1,081)
Serum sodium, mmol/L 135 (115–146)
Lactate dehydrogenase, U/L 275 (118–2,297)
Total bilirubin, μmol/L 24 (4–416)
Plasma lactate, mmol/L 1.6 (0.5-6.2)
Parasite count
P. falciparum load (asexual parasites/μL) 8,400 (2–1,380,600)
Gametocytes, presence, absence, n (%) 64 (16.0), 337 (84.0)Statistical analysis
All data were not normally distributed (Kolmogorov-
Smirnov test) and are therefore presented as medians
and range. Univariate comparisons were performedmodium falciparum malaria grouped by presence or
Schizontaemia No schizontaemia P value
n = 49 n=352
41 (4–70) 39 (5–78) NS
26 (53.1), 23 (46.9) 266 (75.6), 86 (24.4) 0.0018
38 (77.6) 322 (91.5) 0.0196
5 (10.2) 11 (3.1)
3 (6.1) 7 (2.0)
3 (6.1) 12 (3.4)
30 (61.2) 229 (65.1) NS
15 (30.6) 59 (16.8)
0 (0) 27 (7.7)
0 (0) 8 (2.3)
4 (8.2) 29 (8.2)
35 (71.4) 237 (67.3) NS
6 (12.2) 66 (18.8)
6 (12.2) 33 (9.4)
2 (4.1) 16 (4.5)
38.7 (35.7-41.2) 38.5 (35.5-41.0) NS
105 (68–150) 92 (45–150) 0.0002
118 (64–160) 120 (73–190) NS
5 (10.2) 4 (1.1) 0.0019
2 (4.1) 3 (0.9) NS
7.8 (3.8-10.9) 8.4 (2.5-11.1) NS
6.1 (2.5-18.5) 5.0 (1.3-13.4) 0.011
38 (10–164) 94 (2–385) <0.0001
166 (22–476) 87 (5–373) <0.0001
110 (39–1,081) 95 (47–871) 0.0019
132 (115–142) 135 (119–146) <0.0001
435 (135–2,038) 262 (118–2,297) <0.0001
44 (9–269) 23 (4–416) <0.0001
2.7 (0.6-6.2) 1.5 (0.5-4.7) <0.0001
162,000 (144–1,380,600) 5,430 (2–860,000) <0.0001
11 (22.4), 38 (77.6) 53 (15.1), 299 (84.9) NS
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test. Trends between categorical variables were done
with the Chi square test for Trend. Odds ratios were cal-
culated using the approximation of Woolf. For clinical
reference, the diagnostic performance of schizontaemia
for severe disease was compared to that of the classic
biomarkers serum C-reactive protein and plasma lactate
[13-15]. Binary logistic regression analysis was used to
analyse if schizontaemia was independently associated
with malaria severity. Malaria severity was entered as
the dependent variable. To test its independence from
parasite load and the previously evaluated markers lactate
and C-reactive protein, these were entered as co-variants.
As parasite load was a highly skewed continuous variable
with a logarithmic distribution, the data were transformed
to log-parasitaemia to make them suitable for logistic re-
gression analysis.
Results
Patient characteristics
Between 1 January 1999 and 1 January 2012, a total of
562 cases of imported malaria were seen. Of these cases,
161 cases were caused by non-falciparum Plasmodium
species; 401 infections were caused P. falciparum infec-
tions including three patients who had a mixed infection
(two with P. falciparum and P. ovale, one with P. falcip-
arum and P. vivax, respectively). No patient with a mixed
P. falciparum infection presented with schizontaemia on
admission. These 401 patients with either a pure P.
falciparum infection or a mixed Plasmodium infection
with P. falciparum were included in this study.
Schizontaemia
Schizonts were present on admission in 49 of 401 (12.2%)
patients. The general characteristics of the patients with
presence and absence of schizonts on admission are
shown in Table 1. Males were less likely to present with
schizontaemia than female patients (Odds ratio 0.37 (95%
confidence interval 0.20-0.67), p = 0.0018). Although the
number of patients who acquired P. falciparum malariaTable 2 Outcome measures of patients with imported Plasmo
of schizontaemia on admission
All patients
(n = 401)
Schizonta
(n = 49)
Case-fatalities, n (%) 2 (0.5) 1 (2.0)
Severe malaria, n (%) 62 (15.5) 33 (67.3)
ICU admission, n (%) 92 (22.9) 38 (77.6)
Exchange transfusion, n (%) 40 (10.0) 26 (53.1)
Renal replacement therapy, n (%) 7 (1.7) 4 (8.2)
Mechanical ventilation, n (%) 4 (1.0) 3 (6.5)
Time in hospital, days (range) 5 (0–56) 7 (0–56)outside of Africa was relatively low (n= 26), these patients
tended to present with schizontaemia more frequently
than patients who contracted malaria in Africa (Odds
ratio 0.26 (95% CI 0.086-0.79), p = 0.0259). There were no
differences between patients presenting with and without
schizontaemia with regard to their immune status, ethnic
background and use of malaria chemoprophylaxis, nor did
they differ in duration of symptomatology. As detailed in
Table 1, patients with schizontaemia presented more ill on
admission: they had higher pulse rates, were more likely
to have impaired consciousness and laboratory parameters
were compatible with more severe degree of liver and kid-
ney injury as well as more compromised tissue perfusion
given the higher plasma lactate levels. Other laboratory
parameters revealed that patients with schizontaemia also
presented with significantly higher parasite loads, higher
leucocyte counts, higher C-reactive protein levels and sig-
nificantly lower platelet counts. When the WHO severity
criteria for malaria [9] were assessed in both patient
groups, patients with schizontaemia were more likely to
present with or develop severe and complicated disease
and they had to stay significantly longer in hospital than
patients without demonstrable schizontaemia on admis-
sion (Table 2). Death occurred in two of 401 malaria
patients, one with and one without schizontaemia on ad-
mission. Presence of schizontaemia on admission signifi-
cantly increased with increasing parasite loads on
admission (Chi square test for Trend, p < 0.0001), as
shown in Figure 1.
The diagnostic accuracy of schizontaemia as a pre-
dictor for severe malaria was characterized by a high spe-
cificity, negative predictive value and an acceptable
positive predictive value. When compared to the per-
formance of plasma lactate, schizontaemia had a lower
sensitivity but a higher specificity and positive predictive
value for severe disease. When compared to the perform-
ance of C-reactive protein, schizontaemia had a higher
specificity and positive predictive value for severe disease
(Table 3). Using binary logistic regression analysis, schi-
zontaemia was found to be an independent predictor fordium falciparum malaria, grouped by presence or absence
emia No schizontaemia
(n = 352)
P-value Odds ratio
(95% CI)
1 (0.3) NS
29 (8.2) <0.0001 23.0 (11.3-46.6)
54 (15.3) <0.0001 19.1 (9.2-39.6)
14 (4.0) <0.0001 27.3 (12.6-59.2)
3 (0.9) 0.0053 10.3 (2.2-47.7)
1 (0.3) 0.0063 22.9 (2.3-224.8)
5 (0–19) <0.0001
Figure 1 The percentage of patients with schizontaemia on
admission, stratified by peripheral parasite count.
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that found for C-reactive protein and lactate but not that
found for parasite load (Table 4).
Discussion
Sequestration of parasitized erythrocytes in the microvas-
culature of vital organs is a cardinal feature of P. falcip-
arum malaria and is a cause of major pathology in severe
disease [1-4]. Maturing P. falciparum parasites disappear
from the peripheral blood after 24–26 hours to complete
the asexual life cycle in the microvasculature, as the ten-
dency to adhere to the endothelial wall increases duringTable 3 Descriptive statistics of schizontaemia, lactate
and C-reactive protein as predictors for severe malaria
Schizontaemia
(presence)
Plasma lactate
(mmol/L)
C-reactive
protein(mg/L)
Number 401 240 381
Median (range) N/A 1.6 (0.5-6.2) 98 (5–476)
Mean N/A 1.9 111
Standard deviation N/A 1.05 78
Optimal cut-off N/A ≥1.7 ≥142
Sensitivity 0.53 (0.40-0.66) 0.80 (0.67-0.89) 0.76 (0.63-0.86)
Specificity 0.95 (0.92-0.97) 0.63 (0.55-0.70) 0.75 (0.70-0.80)
Youden’s index 0.48 0.43 0.51
PPV 0.67 (0.52-0.80) 0.39 (0.30-0.49) 0.35 (0.27-0.45)
NPV 0.92 (0.88-0.94) 0.91 (0.85-0.95) 0.95 (0.91-0.97)the maturation process [6]. This process of sequestration
accounts for the fact that peripheral parasite counts do
not always correlate well with the sequestered parasite
burden. This discrepancy was noted soon after the use of
the peripheral parasitaemia to predict the outcome of P.
falciparum infection became common practice in the
1930s [5].
In the microvasculature, rupturing schizonts release
up to 32 merozoites [7,16], causing an exponential rise
in parasitaemia. A high schizont count is therefore
likely to precede a rise in parasitaemia and might be
an early marker for severe disease. The presence of
schizontaemia may also be relevant to guide selection
of parenteral treatment. As compared to quinine, arte-
misinin derivatives like artesunate have an anti-
malarial efficacy to the broadest spectrum of parasite
stages, including the generally less drug-sensitive schi-
zonts [1,7]. This may provide another argument to
treat patients with schizontaemia with artemisinin deri-
vatives given the convincing proof of past studies in
regions of malaria endemicity showing that artesunate
was superior over quinine for treatment of severe mal-
aria in both children and adult patients [17,18], not
only in terms of reduction of mortality and parasite
clearance but also in ease of use. Recent studies in
non-endemic industrialized regions confirmed that in
non-immune travellers with imported malaria, treat-
ment with artesunate results in a comparable rapid
parasite clearance to that observed in semi-immune
individuals [19,20].
In the present study schizontaemia was found to be a
useful marker for severe malaria. Although schizontae-
mia was more frequently seen in patients with high-
grade parasitaemia, the predictive power appeared to be
independent of parasitaemia. In the study by Silamut
and White [6] in adult Thai patients and children from
The Gambia, it was demonstrated that a predominance
of mature parasite forms in the peripheral blood reflect
a greater sequestered parasite mass and the presence of
>10 4 mature trophozoites and schizonts per μL of per-
ipheral blood was found to have a high sensitivity (90%)
and specificity (70%) for fatal outcome. The data of the
present study confirm the prognostic value of schizon-
taemia for severe disease in predominantly non-immune
travellers, comparable to that observed in semi-immune
patients in region of malaria endemicity. However, it
should be noted that besides differences in presumed
immunity towards malaria, the current study also dif-
fered in its design with regard to outcome. In many
studies in malaria-endemic regions, the primary out-
come measure is usually survival or death and studies
are restricted to these severe cases using the WHO se-
verity criteria as an entry criterion. Since case fatalities
are less common in the western non-endemic, resource-
Table 4 Results of binary logistic regression analysis of explanatory variables for severe malaria
β S.E. β Wald’s χ df P value Odds ratio (95% CI)
C-reactive protein 0.01 0.04 8.326 1 0.004 1.01 (1.00-1.02)
Log parasitaemia 2.65 0.56 22.325 1 <0.001 14.13 (4.71-42.38)
Plasma lactate 0.42 0.27 3.564 1 NS 1.52 (0.89-2.57)
Schizontaemia 1.87 0.62 9.024 1 0.003 6.52 (1.92-22.13)
Constant -16.63 2.93 32.133 1 <0.001 N/A
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imported disease, the present study in patients with
imported malaria focused on severe malaria as the pri-
mary outcome, using the WHO criteria to define disease
severity.
Unfortunately, for the present study quantitative counts
of the different parasite stages were not available. Al-
though quantification would likely have resulted in a more
precise estimation of its prognostic value, the specificity of
schizontaemia was found to be a useful tool for exclusion
of severe disease. The negative predictive value of schizon-
taemia is high, and comparable to that of C-reactive pro-
tein and lactate. Moreover, unlike C-reactive protein and
lactate [13-15] schizontaemia on admission was also asso-
ciated with a high positive predictive value. This may pro-
vide the clinician with a helpful tool for decision making
in the acute care setting by allowing an early identification
of those malaria patients who are at risk of a more severe
and complicated course than would normally be expected
when considering peripheral parasitaemia alone.
Conclusion
Absence of schizonts on admission in travellers with
imported P. falciparum malaria was found to be a spe-
cific marker for exclusion of severe disease; in contrast,
presence of schizonts had a high positive predictive
value for presence of severe disease and can thus help to
identify patients that may be candidates in need of in-
tensive monitoring and timely administration of prefer-
ably (parenteral) artemisinin derivatives.
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